跳至主要内容
临床试验/NCT02128802
NCT02128802已完成不适用

Weight Reduction Surgery Followed by Kidney Transplantation for Patients with Class III Obesity and Renal Failure

Vanderbilt University Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Ability to reach medical suitability for renal transplant within 18 months after initiating treatment and the change and trajectory of health-related quality of life (HRQOL)

研究概览

简要总结

Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Body mass index 40-55 kg/m2
  • Age less than 60 years
  • Available support person
  • Adequate insurance
  • All other criteria required for renal transplantation

排除标准

  • Schizophrenia
  • Bipolar disorder
  • Crohn's disease
  • Human Immunodeficiency Virus
  • Cirrhosis
  • Prior weight loss surgery
  • Prior mesh hernia repair
  • Prior anti-reflux surgery
  • Inability to walk 200 feet
  • Significant coronary disease
  • Significant lung disease - Fixed expiratory volume 1 less than 75% or on oxygen
  • Addiction to alcohol or drugs
  • Inability to quit smoking
  • Jehovah's witness
  • Non-compliance with dialysis regimen
  • Previous renal transplant
  • Non-English speaking

结局指标

主要结局

Ability to reach medical suitability for renal transplant within 18 months after initiating treatment and the change and trajectory of health-related quality of life (HRQOL)

时间窗: 18 months

Outcomes will be measured based on weight loss and a variety of validated surveys and questionnaires to measure HRQOL

次要结局

  • Weight loss(5 years)
  • Nutritional status(5 years)
  • All-cause mortality(5 years)
  • Health care utilization(5 years)
  • Hormonal and metabolic status(5 years)
  • Surgical outcomes(5 years)
  • Development or regression of diabetes(5 years)
  • Development or regression of other comorbidities(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seth Karp

Professor

Vanderbilt University Medical Center

研究点 (2)

Loading locations...

相似试验